Kory Lavine, MD, PhD

Cardio-Oncologist

Kory Lavine

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Center for Advanced Medicine

Center for Advanced Medicine

On WashU Medicine Campus
4921 Parkview Place, Saint Louis, MO 63110

Expertise & Training

Clinical Expertise

  • Heart failure associated with cancer treatment

Primary Academic Title

Professor of Medicine, Division of Cardiovascular Diseases, WashU Medicine

Board Certification

  • 2011: American Board of Internal Medicine
  • 2015: American Board of Internal Medicine - Cardiovascular Disease
  • 2016: American Board of Internal Medicine - Advanced Heart Failure and Transplant Cardiology

Training

  • 2008 - 2010: Resident, Internal Medicine, WashU Medicine, St. Louis, MO
  • 2010 - 2013: Fellow, Cardiovascular Medicine, WashU Medicine, St. Louis, MO
  • 2013 - 2014: Fellow, Advanced Heart Failure and Transplant, WashU Medicine, St. Louis, MO

Education

  • 2008: MD/PhD, WashU Medicine, St. Louis, MO

Research & Selected Publications

Research Interest

Heart failure, including cardiomyopathies associated with chemotherapy

Research Publications

Lymphatic disruption drives lung transplant fibrosis through interleukin-1-mediated hyaluronan accumulation
Authors:

Shepherd HM, Li W, Kopecky BJ, one or more additional authors omitted Lavine KJ, one or more additional authors omitted Kreisel D

Journal & Year:

Sci Transl Med | 2026

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic
Authors:

Somani VK, Zhang X, Chen TH, one or more additional authors omitted Lavine KJ, one or more additional authors omitted Lim KH

Journal & Year:

Mol Cancer | 2026

DNA-damaging chemotherapy reshapes cardiac-resident macrophage composition and function
Authors:

He R, Kadyrov FF, Koenig AL, one or more additional authors omitted Lavine KJ

Journal & Year:

Sci Immunol | 2026

An unbiased proteomic platform for ATE1-based arginylation profiling
Authors:

Lin Z, Xie Y, Gongora J, one or more additional authors omitted Lavine KJ, one or more additional authors omitted Garcia BA

Journal & Year:

Nat Chem Biol | 2025

Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
Authors:

Guo Z, Ataran A, Ma P, one or more additional authors omitted Lavine KJ, Javaheri A

Journal & Year:

Circulation | 2025

Ischemic Injury Drives Nascent Tumor Growth Via Accelerated Hematopoietic Aging
Authors:

Newman AAC, Barcia Durán JG, Von Itter R, one or more additional authors omitted Lavine KJ, one or more additional authors omitted Moore KJ

Journal & Year:

JACC CardioOncol | 2025

The immune checkpoint regulator CD40 potentiates myocardial inflammation
Authors:

Jimenez J, Amrute J, Ma P, one or more additional authors omitted Lavine KJ

Journal & Year:

Nat Cardiovasc Res | 2025

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Authors:

Iglesia MD, Jayasinghe RG, Chen S, one or more additional authors omitted Lavine K, one or more additional authors omitted Ding L

Journal & Year:

Nat Cancer | 2024